Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14
LOS ANGELES, May 13, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the […]